| scholarly article | Q13442814 |
| P2093 | author name string | Sangeeta T Mahajan | |
| Bogdan Orasanu | |||
| P2860 | cites work | Botulinum toxin type A (BOTOX) for treatment of migraine | Q34146010 |
| Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as "Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus" in Zeitschrift für Hygiene und Infektionskra | Q34198222 | ||
| Botulinum neurotoxins are zinc proteins | Q34260095 | ||
| Botulinum toxin as a new therapy option for voiding disorders: current state of the art. | Q35183026 | ||
| Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra | Q36018771 | ||
| Botulinum toxin: from life-threatening disease to novel medical therapy | Q36714084 | ||
| Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. | Q36995681 | ||
| Refractory idiopathic urge urinary incontinence and botulinum A injection. | Q37004158 | ||
| Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience | Q37197554 | ||
| Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. | Q37281713 | ||
| Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence | Q37325841 | ||
| Botulinum Toxin Therapy for Neurogenic Detrusor Overactivity | Q37801072 | ||
| A comparison of botulinum toxin and saline for the treatment of chronic anal fissure | Q39451471 | ||
| Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction | Q39981327 | ||
| Motor nerve sprouting in human orbicularis muscle after botulinum A injection. | Q43421494 | ||
| Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. | Q44045350 | ||
| Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships | Q46172540 | ||
| Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results | Q46349100 | ||
| Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence | Q46434816 | ||
| Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity | Q46586297 | ||
| European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity | Q47892069 | ||
| Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial. | Q47956298 | ||
| Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study | Q48558961 | ||
| Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury | Q48744935 | ||
| Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany. | Q49073287 | ||
| Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. | Q51347644 | ||
| Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia. | Q51732450 | ||
| Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. | Q51750887 | ||
| Botulinum toxin a for idiopathic detrusor overactivity | Q53061344 | ||
| Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial. | Q53155089 | ||
| Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. | Q53194715 | ||
| Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. | Q53856599 | ||
| Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization | Q59098730 | ||
| Repeated Injections of Botulinum Toxin-A for Idiopathic Detrusor Overactivity | Q62626416 | ||
| Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction | Q66829168 | ||
| Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study | Q68697019 | ||
| Treatment of anismus in intractable constipation with botulinum A toxin | Q69923868 | ||
| Development of resistance to botulinum toxin type A in patients with torticollis | Q72476569 | ||
| Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia | Q73343682 | ||
| Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results | Q74206910 | ||
| Clinical trials of botulinum toxin in the treatment of spasticity | Q77594639 | ||
| Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity | Q78462264 | ||
| Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity | Q79400222 | ||
| Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore | Q79736323 | ||
| Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study | Q80973713 | ||
| Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity | Q81546025 | ||
| Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study | Q81833229 | ||
| Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients | Q82588707 | ||
| Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children | Q82692047 | ||
| Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity | Q83275316 | ||
| Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis | Q83445672 | ||
| Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics | Q83925469 | ||
| Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder | Q84596109 | ||
| Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years | Q85056755 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2-11 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Indian Journal of Urology | Q6020825 |
| P1476 | title | The use of botulinum toxin for the treatment of overactive bladder syndrome | |
| P478 | volume | 29 |
| Q39307792 | Autonomic dysreflexia after spinal cord injury: Systemic pathophysiology and methods of management |
| Q40047417 | Is there any Relationship Between Bladder Trabeculation and Efficacy and Safety of Intravesical Botulinum Toxin A Injection in Refractory Idiopathic Overactive Bladder Women? |
| Q98159685 | Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study |
Search more.